Loading...
INSM INSMED INC US FDA Inspections 8-K Filing
Back
NSMD
NSM
INSMED INC
(INSM)
Follow
FY2025 8 K
View More
Back
NSMD
NSM
INSMED INC
(INSM)
Follow
FY2025 8 K
Filing:
8 K
Published on:
6 Feb '25
Financial Statements
8 May '25
Rights Offerings
24 Apr '25
Debt-Equity Swaps
24 Apr '25
Management Change
17 Apr '25
FDA Update
24 Feb '25
Financial Results
20 Feb '25
FDA Review Accepted
6 Feb '25
Investor Conference
10 Jan '25
Agreement Termination
19 Nov '24
Loan Agreement Update
31 Oct '24
Redemption of Notes
9 Aug '24
Financial Results Press Rel...
8 Aug '24
Regulation FD Disclosure
3 Jul '24
Redemption of Convertible S...
27 Jun '24
Notice from AstraZeneca
13 Jun '24
Webinar on Market Outlook
4 Jun '24
Underwriting Agreement
30 May '24
Positive Phase 3 results fo...
28 May '24
Approval of Amendment to In...
13 May '24
Financial Results and Safet...
9 May '24
Other Events
11 Mar '24
Sales Agreement and Financi...
22 Feb '24
Regulation FD Disclosure
5 Jan '24
Financial Results Press Rel...
26 Oct '23
Financial Results Press Rel...
3 Aug '23
Annual Meeting and Approval...
11 May '23
Investor Event
8 May '23
Earnings Reports
4 May '23
Earnings Reports
23 Feb '23
Regulation FD Disclosure
6 Jan '23
External Links:
SEC
AI Assistant
Close
INSMED INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.